Theralink Technologies, Inc.
THER
$0.0001
$0.000.00%
OTC PK
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Net Income | -13.50M | -30.91M | -48.21M | -54.42M | -47.69M |
Total Depreciation and Amortization | 204.10K | 208.30K | 204.10K | 200.30K | 193.70K |
Total Amortization of Deferred Charges | 16.70M | 15.28M | 10.89M | 6.52M | 2.25M |
Total Other Non-Cash Items | -12.07M | 6.56M | 29.89M | 40.80M | 38.74M |
Change in Net Operating Assets | 3.71M | 3.08M | 2.02M | 804.70K | 830.90K |
Cash from Operations | -4.96M | -5.77M | -5.20M | -6.09M | -5.67M |
Capital Expenditure | -155.40K | -163.40K | -51.40K | -134.90K | -139.60K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -155.40K | -163.40K | -51.40K | -134.90K | -139.60K |
Total Debt Issued | 4.31M | 6.97M | 5.37M | 6.26M | 6.86M |
Total Debt Repaid | -301.00K | -423.00K | -172.40K | -170.80K | -169.20K |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -19.70K | -80.20K | -139.40K |
Other Financing Activities | -- | -- | -27.30K | -27.30K | -27.30K |
Cash from Financing | 4.01M | 6.54M | 5.15M | 5.98M | 6.53M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -1.11M | 604.00K | -100.40K | -239.70K | 715.80K |